Real Estate / Real Estate ServicesUpdated 2026-05-10 22:07 UTC

BME/CLNX stock hub

BME/CLNX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/CLNXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19B

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/CLNX

In the news

Latest news · BME/CLNX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.8P50 18.7P75 25.9

Trailing P/En/a

P25 9.7P50 14.2P75 24.9

ROE-2.4

P25 1.7P50 4.8P75 9.9

ROIC1.6

P25 1.5P50 2.9P75 4.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/CLNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

EUR

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	2,494
Employees Change	-148%
Employees Change Percent	-5.6
Enterprise value	EUR 40.5B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Real Estate Services
Isin	ES0105066007
Last refreshed	2026-05-10
Market cap	EUR 19B
Price	EUR 28.17
Price currency	EUR
Rev Per Employee	1,660,087.01x
Sector	Real Estate
Sic	4899
Symbol	bme/CLNX
Website	https://www.cellnex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.84%
EV Earnings	-116.24x
EV/EBIT	71.84x
EV/EBITDA	12.58x
EV/Sales	9.79x
P/B ratio	1.44x
P/S ratio	4.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.35%
EBITDA Margin	61.86%
Gross margin	88.9%
Gross Profit	EUR 3.7B
Gross Profit Growth	-0.01%
Gross Profit Growth Q	3.64%
Gross Profit Growth3 Y	7.22%
Gross Profit Growth5 Y	20.12%
Net Income	EUR -348.8M
Net Income Growth Years	0%
Pretax Margin	-9.66%
Profit Margin	-8.42%
Profit Per Employee	EUR -139,846
ROA	0.81
Roa5y	0.54
ROCE	1.44
ROE	-2.39
Roe5y	-1.99
ROIC	1.64
Roic5y	1.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.66%
Cagr1y	-17.85%
Cagr3y	-9.15%
Cagr5y	-9.62%
Div CAGR3	94.49%
Div CAGR5	42.3%
EPS Growth Years	0
Revenue Growth	0.81x
Revenue Growth Q	-8.38x
Revenue Growth Quarters	5x
Revenue Growth Years	12x
Revenue Growth3 Y	6.74x
Revenue Growth5 Y	19.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.1
Assets	EUR 42.9B
Cash	EUR 2.9B
Current Assets	EUR 4.1B
Current Liabilities	EUR 4.5B
Debt	EUR 23.2B
Debt EBITDA	EUR 7.22
Debt Equity	EUR 1.75
Equity	EUR 13.2B
Interest Coverage	1.02
Liabilities	EUR 29.6B
Long Term Assets	EUR 38.8B
Long Term Liabilities	EUR 25.2B
Net Cash	EUR -20.3B
Net Cash By Market Cap	EUR -107
Net Debt EBITDA	EUR 7.93
Net Debt Equity	EUR 1.54
Tangible Book Value	EUR -9.4B
Tangible Book Value Per Share	EUR -14
WACC	6.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	54.06
Net Working Capital	EUR -632M
Quick ratio	0.9
Working Capital	EUR -399M
Working Capital Turnover	EUR -6.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	518.8%
Dividend Growth Years	0%
Dividend per share	EUR 0.39
Dividend Years	12
Dividend Yield	1.38%
Ex Div Date	2026-01-13
Last Dividend	EUR 0.37
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	175.3%
1Y total return	-17.84%
200-day SMA	28.36
3Y total return	-25.02%
50-day SMA	28.84
50-day SMA vs 200-day SMA	50over200
5Y total return	-39.69%
All Time High	61.92
All Time High Change	-54.51%
All Time High Date	2021-08-24
All Time Low	12.55
All Time Low Change	124.46%
All Time Low Date	2016-11-14
ATR	0.78
Beta	1.28
Beta1y	0.96
Beta2y	0.7
Ch YTD	2.7
High	28.36
High52	34.85
High52 Date	2025-05-08
High52ch	-19.17%
Low	27.84
Low52	24.72
Low52 Date	2026-03-23
Low52ch	13.96%
Ma50ch	-2.32%
Price vs 200-day SMA	-0.68%
RSI	44.94
RSI Monthly	44.49
RSI Weekly	48.93
Sharpe ratio	-0.56x
Sortino ratio	-0.53
Total Return	1.38%
Tr YTD	4.12
Tr1m	-3.26%
Tr1w	-1.81%
Tr3m	2.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 552.9M
Operating Income Growth	-8.87
Operating Income Growth Q	6.67
Operating Income Growth3 Y	28.91
Operating Income Growth5 Y	27.25
Operating margin	13.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	524,255,243%
Shares Insiders	0.47%
Shares Institutions	46.52%
Shares Out	673,839,490
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,346,445.45x
Bv Per Share	17.76
Ch10y	101.9
Ch1m	-3.26
Ch1w	-1.81
Ch1y	-19.01
Ch3m	2.66
Ch3y	-26.35
Ch5y	-40.91
Ch6m	5.9
Change	-0.07%
Change From Open	0.61
Close	28.19
Days Gap	-0.67
Depreciation Amortization	2,008,126,000
Dollar Volume	25,756,704.3
Earnings Date	2026-04-29
EBIT	EUR 552.9M
EBITDA	EUR 2.6B
EPS	EUR -0.52
F Score	3
Fiscal Year End	December
Founded	2,008
Income Tax	EUR -62.1M
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	27.76
Ma150ch	1.47%
Ma20	28.82
Ma20ch	-2.25%
Next Earnings Date	2026-07-31
Open	28
Payment Date	2026-01-15
Position In Range	63.46
Ppne	16,019,000,000
Price Date	2026-05-08
Price EBITDA	EUR 7.41
Relative Volume	0.69x
Revenue	4,140,257,000x
Tax By Revenue	-1.5x
Tr6m	7.37%
Volume	914,331
Z Score	0.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/CLNX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.39 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+42.3%

0 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2026-01-13

Performance

BME/CLNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/CLNX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/CLNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

-0.7%

50/200-day relationship not available

Beta (5Y)

1.28

More volatile than the market

Sharpe ratio

-0.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/CLNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/CLNX stock rating?

bme/CLNX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/CLNX analysis?

The full report lives at /stocks/bme/CLNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/CLNX?

The latest report frames bme/CLNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/CLNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.